::

The US Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli’s challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug’s price by more than 4,000%.
Convicted “Pharma Bro” Martin Shkreli has been ordered to return $64 million in profits his company made by inflating the price of a life-saving drug, a federal judge in New York ruled on Friday.
A three-judge panel of the 2nd US Circuit Court of Appeals said a lower court judge acted properly in imposing the ban because of Shkreli’s antitrust violations.